Breast cancer patients may soon have no worries, but surely, as always, they just have to do one thing - Go For Regular Tests

There is near breakthrough in one research process which is ongoing at the University of Michigan (UM).

A group of researchers are developing a pill that makes tumours light up when exposed to infrared light, and the concept has worked in mice.

Killing cancer cells with the help of infrared light is called Photoimmunotherapy.

Researchers working on the Infrared Light cancer treatment, said when near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die.

Photoimmunotherapy is in clinical trials in patients with inoperable tumours. 

One of the researchers developing the pill in Michigan, Greg Thurber, UM assistant professor of chemical engineering and biomedical engineering, said the pill was "actually based on a failed drug”.

Also Read: Hawker’s Breast Puts Bricklayer In Trouble

His statement was contained in a statement on UM's website.

“It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”

The statement said drug targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. 

The researchers attached a molecule that fluoresces when it is struck with infrared light to this drug.

Then, they gave the drug to mice that had breast cancer, and they saw the tumours light up.

The move could also catch cancers that would have gone undetected.

By providing specific information on the types of molecules on the surface of the tumuor cells, physicianscan better distinguish a malignant cancer from a benign tumour.

Moreover, using a dye delivered orally rather than directly into a vein also improves the safety of screening.

Cancer screening in Nigeria is largely free and this is why women should take advantage of it.

Also Read: Why Men Over 40 Should Go For Prostate Cancer

Millions of women are screened every year in the U. S. alone and a study out of Denmark last year, showed about a third of breast cancer patients treated with surgery or chemotherapy have tumours that are benign or so slow-growing that they would never have become life-threatening.

The Michigan University researchers report has been published in the journal Molecular Pharmaceutics.